SMAD2 and idiopathic pulmonary fibrosis: Surprisingly, recent evidence suggests that, TGF-β1 could activate STAT3 through a Smad2/3-dependent mechanism to exert profibrotic effects in the fibroblasts of IPF patients, not dependent on JAK2 [32].